Science

3D visualization of the Westlake University super antibody neutralizing the SFTS virus.

Westlake University’s ‘Super Antibody’ ZS1C5 Targets Deadly SFTS Virus with 100% Survival in Animal Trials

Scientists at Westlake University have engineered a “super antibody” that achieved 100% survival in mice exposed to a deadly tick-borne virus. The therapy, called ZS1C5, slashed viral loads in monkeys by 90% in 24 hours, offering the first hope for a targeted treatment against SFTS—a disease with a 30% fatality rate and no current cure.

Read More...